Published in BMC Neurosci on April 27, 2006
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat Rev Neurosci (2011) 1.30
Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev (2011) 1.22
Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother (2010) 0.99
Hospital-diagnosed dementia and suicide: a longitudinal study using prospective, nationwide register data. Am J Geriatr Psychiatry (2008) 0.96
Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice. Mol Psychiatry (2012) 0.87
A review of the literature on neuroimaging of serotoninergic function in Alzheimer's disease and related disorders. J Neural Transm (Vienna) (2007) 0.83
Development of the human insular cortex: differentiation, proliferation, cell death, and appearance of 5HT-2A receptors. Histochem Cell Biol (2008) 0.83
Merkel disc is a serotonergic synapse in the epidermis for transmitting tactile signals in mammals. Proc Natl Acad Sci U S A (2016) 0.80
Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task. Psychopharmacology (Berl) (2008) 0.80
ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility. Br J Pharmacol (2014) 0.78
Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals. Age (Dordr) (2010) 0.77
The serotonergic system and cognitive function. Transl Neurosci (2016) 0.75
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases. Front Neurosci (2016) 0.75
The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component. Pharmacol Biochem Behav (2007) 0.75
Ovarian hormones ameliorate memory impairment, cholinergic deficit, neuronal apoptosis and astrogliosis in a rat model of Alzheimer's disease. Exp Ther Med (2015) 0.75
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT. Front Pharmacol (2016) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
A review of central 5-HT receptors and their function. Neuropharmacology (1999) 6.13
The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.14
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am J Psychiatry (2003) 1.86
Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol (1999) 1.72
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol (2000) 1.63
5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A (1998) 1.61
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci (2004) 1.61
Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev (2000) 1.59
Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther (2000) 1.58
Serotonin brain circuits involved in major depression and suicide. Prog Brain Res (2002) 1.52
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse (1997) 1.38
The physiological role of 5-HT2A receptors in working memory. J Neurosci (2002) 1.23
Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol (2000) 1.22
Cholinergic function and Alzheimer's disease. Int J Geriatr Psychiatry (2003) 1.20
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry (2002) 1.17
Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia (2005) 1.10
Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem (1987) 1.09
Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease. Int J Geriatr Psychiatry (2004) 1.09
Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem (1996) 1.08
Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol (2003) 1.08
Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc Natl Acad Sci U S A (1989) 1.05
Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience (1995) 1.04
Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry (2005) 1.02
Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol (1984) 1.00
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet (1998) 1.00
Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem (1984) 0.98
The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. Am J Geriatr Psychiatry (1998) 0.97
Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol (2004) 0.94
Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication. J Neurochem (1996) 0.93
Practical measures to simplify the Braak tangle staging method for routine pathological screening. Acta Neuropathol (2000) 0.92
Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci (2001) 0.92
PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. Am J Psychiatry (1999) 0.91
Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology (2004) 0.89
Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J Neurochem (1999) 0.89
5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. Synapse (2002) 0.87
Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci (1997) 0.87
Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex. Neuroscience (2001) 0.86
Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol (1999) 0.84
Topographical distribution of neurochemical changes in Alzheimer's disease. J Neurol Sci (1988) 0.84
The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biol Psychiatry (1998) 0.84
Depression in Alzheimer's disease: the effect of serotonin receptor gene variation. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochem Res (1992) 0.83
Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Psychopharmacology (Berl) (2004) 0.82
Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience (1999) 0.82
5-ht6 receptors as emerging targets for drug discovery. Annu Rev Pharmacol Toxicol (2000) 0.82
Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison. Exp Gerontol (1999) 0.81
Neuropathology of aminergic nuclei in Alzheimer's disease. Prog Clin Biol Res (1989) 0.81
Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease. J Neural Transm (Vienna) (2001) 0.78
[Serotonergic control of prefrontal cortex]. Rev Neurol (2004) 0.78
Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese. Neurosci Lett (2004) 0.78
Aging and Alzheimer's disease. Altered cortical serotonergic binding. Arch Neurol (1989) 0.77
5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. J Neural Transm Park Dis Dement Sect (1990) 0.77
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet (2011) 6.98
Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol (2007) 5.53
Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature (2003) 5.04
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature (2012) 4.37
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer (2009) 3.90
A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol Cell (2003) 3.88
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 3.88
Single-layer MoS2 phototransistors. ACS Nano (2011) 3.43
Probe selection for high-density oligonucleotide arrays. Proc Natl Acad Sci U S A (2003) 3.31
Gene structure-based splice variant deconvolution using a microarray platform. Bioinformatics (2003) 2.97
Comparative and functional genomic analyses of the pathogenicity of phytopathogen Xanthomonas campestris pv. campestris. Genome Res (2005) 2.65
Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology (2011) 1.93
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem (2005) 1.92
ANOSVA: a statistical method for detecting splice variation from expression data. Bioinformatics (2005) 1.88
Fabrication of single- and multilayer MoS2 film-based field-effect transistors for sensing NO at room temperature. Small (2011) 1.69
Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol (2007) 1.61
Tea and cancer prevention: molecular mechanisms and human relevance. Toxicol Appl Pharmacol (2006) 1.61
Single-layer semiconducting nanosheets: high-yield preparation and device fabrication. Angew Chem Int Ed Engl (2011) 1.60
MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol (2011) 1.53
MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell (2011) 1.46
Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem (2012) 1.43
Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell Res (2010) 1.36
Phosphate and R2D2 restrict the substrate specificity of Dicer-2, an ATP-driven ribonuclease. Mol Cell (2011) 1.36
Simple sequence repeat-based consensus linkage map of Bombyx mori. Proc Natl Acad Sci U S A (2005) 1.35
Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair. Cardiovasc Res (2007) 1.34
Specific and modular binding code for cytosine recognition in Pumilio/FBF (PUF) RNA-binding domains. J Biol Chem (2011) 1.32
The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29
A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Res (Phila) (2009) 1.27
p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation (2005) 1.26
Inhibition of carcinogenesis by tea constituents. Semin Cancer Biol (2007) 1.25
miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem (2010) 1.24
Dithienosilole- and dibenzosilole-thiophene copolymers as semiconductors for organic thin-film transistors. J Am Chem Soc (2006) 1.23
Curcumin induces the differentiation of myeloid-derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res (Phila) (2011) 1.21
CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug Metab Dispos (2006) 1.18
Preparation of novel 3D graphene networks for supercapacitor applications. Small (2011) 1.17
Molecular targets for the cancer preventive activity of tea polyphenols. Mol Carcinog (2006) 1.17
Possible mechanisms of the cancer-preventive activities of green tea. Mol Nutr Food Res (2006) 1.17
High-performance transparent inorganic-organic hybrid thin-film n-type transistors. Nat Mater (2006) 1.16
Computational identification and characterization of primate-specific microRNAs in human genome. Comput Biol Chem (2010) 1.11
Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells. J Neurooncol (2010) 1.11
Evaluating multipollutant exposure and urban air quality: pollutant interrelationships, neighborhood variability, and nitrogen dioxide as a proxy pollutant. Environ Health Perspect (2013) 1.10
Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. Mol Biol Cell (2005) 1.09
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasit Vectors (2012) 1.09
Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity. Cancer Prev Res (Phila) (2008) 1.08
Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting. J Neurosci (2010) 1.05
Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI). Neurotoxicology (2011) 1.05
Proliferation and apoptosis in the developing human neocortex. Anat Rec (2002) 1.05
An effective method for the fabrication of few-layer-thick inorganic nanosheets. Angew Chem Int Ed Engl (2012) 1.03
Inhibition of lung cancer growth in mice by dietary mixed tocopherols. Mol Nutr Food Res (2009) 1.03
Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology (2011) 1.03
MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box. J Biol Chem (2011) 1.02
Transcriptional and epigenetic regulation of human microRNAs. Cancer Lett (2012) 1.02
Virological and epidemiological evidence of avian influenza virus infections among feral dogs in live poultry markets, china: a threat to human health? Clin Infect Dis (2014) 1.02
Genome-wide analysis of Aux/IAA gene family in Solanaceae species using tomato as a model. Mol Genet Genomics (2012) 1.02
Genome-wide analysis of the mitogen-activated protein kinase gene family in Solanum lycopersicum. Gene (2012) 1.01
Identification, isolation and expression analysis of auxin response factor (ARF) genes in Solanum lycopersicum. Plant Cell Rep (2011) 1.00
Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact (2009) 1.00
The role of calcium in hypoxia-induced signal transduction and gene expression. Cell Calcium (2004) 0.99
Effects of ageing and Alzheimer's disease on mitochondrial function of human platelets. Exp Gerontol (2008) 0.98
Optical identification of single- and few-layer MoS₂ sheets. Small (2012) 0.98
The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain. Neurochem Int (2007) 0.98
Amyloid-β induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J Alzheimers Dis (2010) 0.97
The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities. Glia (2008) 0.97
Mechanical exfoliation and characterization of single- and few-layer nanosheets of WSe₂ , TaS₂ , and TaSe₂. Small (2012) 0.97
Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr Cancer (2007) 0.97
Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics (2006) 0.96
Highly flexible polyelectrolyte nanotubes. J Am Chem Soc (2003) 0.96
Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation. Cancer (2009) 0.95
Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response. J Neurol Sci (2008) 0.95
Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice. PLoS One (2011) 0.94
Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. J Dermatol Sci (2012) 0.93
Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis. Parasit Vectors (2013) 0.93
Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics (2009) 0.93
Trophism of neural progenitor cells to embryonic stem cells: neural induction and transplantation in a mouse ischemic stroke model. J Neurosci Res (2007) 0.93
Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice. Int J Mol Sci (2010) 0.92
Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma. Int J Cancer (2008) 0.92
Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics (2007) 0.92
Catabolism of branched-chain amino acids in heart failure: insights from genetic models. Pediatr Cardiol (2011) 0.92
Preparation of MoS₂-polyvinylpyrrolidone nanocomposites for flexible nonvolatile rewritable memory devices with reduced graphene oxide electrodes. Small (2012) 0.92
Polyamine accumulation in transgenic tomato enhances the tolerance to high temperature stress. J Integr Plant Biol (2009) 0.91
A fMRI study of age-related differential cortical patterns during cued motor movement. Brain Topogr (2005) 0.91
Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells. Cancer Lett (2008) 0.91
Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics (2004) 0.91
Alpha-crystallin protected axons from optic nerve degeneration after crushing in rats. J Mol Neurosci (2008) 0.91
Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. J Bioenerg Biomembr (2007) 0.90
Rapid and reliable thickness identification of two-dimensional nanosheets using optical microscopy. ACS Nano (2013) 0.90
Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction. PLoS One (2013) 0.90
ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells. J Pathol (2014) 0.89
Genome-wide analysis of SAUR gene family in Solanaceae species. Gene (2012) 0.89
Age related changes of various markers of astrocytes in senescence-accelerated mice hippocampus. Neurochem Int (2005) 0.89
The toxic effect of ketamine on SH-SY5Y neuroblastoma cell line and human neuron. Microsc Res Tech (2010) 0.89
Chronic ketamine administration modulates midbrain dopamine system in mice. PLoS One (2012) 0.88
Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine. Toxicol Lett (2010) 0.87
Effects of genistein on hippocampal neurodegeneration of ovariectomized rats. J Mol Neurosci (2007) 0.86
DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice. BMC Infect Dis (2013) 0.86
Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial. BMC Infect Dis (2013) 0.86